© Globe Newswire
28.01.2026
AMRX
LISTED
NASDAQ
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
News Preview
BRIDGEWATER, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has been added to the S&P SmallCap 600® Index. The inclusion will become effective prior to the opening of trading on Friday, January 30, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.01.2026
KDEV
LISTED
STO
Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.01.2026
INDV
LISTED
NASDAQ
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
News Preview
RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m. U.S. EST. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members o...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
28.01.2026
COPN
LISTED
SIX
Invitation to Cosmo's Full Year 2025 Financial Results Webcast on 9 March 2026
News Preview
Dublin, Ireland--(Newsfile Corp. - January 28, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced today that it will publish its Full-Year 2025 results on Monday, 9 March 2026 at 7:00 am CET. Live conference call and audio webcast presentation: Cosmo invites investors...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© ActuNews
27.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
News Preview
Lyon, France – 27 janvier 2026, 18h CET – THX Pharma (Theranexus), société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui le bilan semestriel de son contrat de liquidité confié à Portzamparc.
Au titre du contrat de liquidité confié...
Themefolio
Profiler
Peergroup
© BusinessWire
27.01.2026
BAYN
LISTED
XETR
Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada
News Preview
Bayer Crop Science today announced an unprecedented $45+ million CAD investment to strengthen Canada’s leadership in canola innovation by establishing a cutting-edge canola innovation centre. Located in Winnipeg, Manitoba, the facility will house seed development work for canola, camelina and winter canola, focusing on trait integration, yield tri...
Themefolio
Profiler
Peergroup
© BusinessWire
27.01.2026
TEM
LISTED
NASDAQ
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune Profile Score (IPS), more accurately predicts outcomes for patients receiving immune checkpoint inhibitors (ICIs) than conventional biomarkers, includ...
Themefolio
Profiler
Peergroup
© BusinessWire
27.01.2026
BAYN
LISTED
XETR
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
News Preview
Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during two late-breaking sessions at the upcoming American Stroke Association’s International Stroke Conference (ISC) 2026. The conference will be held February 4-6 in New Orleans, Lou...
Themefolio
Profiler
Peergroup
© BusinessWire
27.01.2026
ICLR
LISTED
NASDAQ
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
News Preview
ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.
The new institute strengthens Accellacare’s ability to support oncology clinical trials and broaden access to innovative...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.01.2026
AMRX
LISTED
NASDAQ
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
News Preview
BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.01.2026
IBAB
LISTED
EURONEXT
IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan
News Preview
Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be instal...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
BIOA B
LISTED
STO
Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)
News Preview
STOCKHOLM, Sweden, Jan. 26, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have submitted a proposed Marketing Authorisation Variation to the European Medicines Agency (EMA) for a once every four weeks intravenous (IV) infusion maintenance dosing for lecanemab.
In the EU, lecanemab is...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
26.01.2026
DFTX
LISTED
NASDAQ
Definium Therapeutics Announces New Employee Inducement Grants
News Preview
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-ex...
Themefolio
Profiler
Peergroup
© ActuNews
26.01.2026
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 26 januari 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© ActuNews
26.01.2026
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – January 26, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on January 23, 2026, from Atlas Special Oppo...
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
ERF
LISTED
EURONEXT
Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software
News Preview
Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highl...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
TRAW
LISTED
NASDAQ
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
News Preview
Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no viral rebounds to date and faster time to sustained symptom resolution; results recapitulated in PAXLOVID®-ineligible patients, representing a significant population with few effective treatment options...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
COLO B
LISTED
CPH
Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET
News Preview
Friday, 6 February 2026 at 11:00-12:00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Col...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
BAVA
LISTED
CPH
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
News Preview
COPENHAGEN, Denmark, January 26, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 7, 2026, under which the Company will repurchase shares for an amount up to DKK 150 million in the period from January 7, 2026 to February 13, 2026. The program is executed in accordance with Regulation...
Themefolio
Profiler
Peergroup
© ActuNews
23.01.2026
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – January 23, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on January 22, 2026, from Atlas Special Oppo...
Themefolio
Profiler
Peergroup
© ActuNews
23.01.2026
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 23 januari 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
KDEV
LISTED
STO
Karolinska Development AB receives additional guarantee commitments in ongoing rights issue
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
BAVA
LISTED
CPH
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
News Preview
Bavarian Nordic has signed a distribution agreement with Eurofarma for its chikungunya vaccine in Brazil with potential to expand to rest of Latin America...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2026
INSP
LISTED
NYSE
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) concerning whether the board breached its fiduciary duties to shareholders.
If you are a shareholder, click HERE to participate.
On August 4, 2025, Inspire disclosed that t...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on January 15, 2026 to 40 new non-executive employees as equity inducemen...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2026
HNSA
LISTED
STO
Hansa Biopharma has won the 2025 SwedenBIO Award
News Preview
LUND, Sweden, Jan. 22, 2026 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that the company has been awarded the prestigious 2025 SwedenBIO Award. The award was presented at the SwedenBIO Summit in Stockholm on 21 January, where Hansa was selected as the winner among the many nominated companies.
Since its in...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2026
HNSA
LISTED
STO
Hansa Biopharma has won the 2025 SwedenBIO Award
News Preview
LUND, Sweden, Jan. 22, 2026 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that the company has been awarded the prestigious 2025 SwedenBIO Award. The award was presented at the SwedenBIO Summit in Stockholm on 21 January, where Hansa was selected as the winner among the many nominated companies.
Since its in...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2026
AFX
LISTED
XETR
Q1 GJ 2025/26 Ergebnis deutlich unter Vorjahr - Prognose für GJ 2025/26 wird voraussichtlich nicht erreicht
News Preview
Q1 GJ 2025/26 Ergebnis deutlich unter Vorjahr - Prognose für GJ 2025/26 wird voraussichtlich nicht erreicht
Jena, 22. Januar 2026
In den ersten drei Monaten des Geschäftsjahres (GJ) 2025/26 bis zum 31. Dezember 2025 erzielte die Carl Zeiss Meditec AG (ISIN: DE0005313704) einen vorläufigen Umsatz von 467 Mio. € (Vorjahr: 490 Mio. €). Der U......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2026
AFX
LISTED
XETR
Q1 FY 2025/26 earnings clearly below past year - FY 2025/26 guidance will likely not be achieved
News Preview
Q1 FY 2025/26 earnings clearly below past year - FY 2025/26 guidance will likely not be achieved
Jena, January 22, 2026
In the first 3 months of fiscal year (FY) 2025/26 ending December 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) recorded preliminary revenue of € 467 million (prior year: € 490 million). The revenue decline was ma......
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
ACB
LISTED
NASDAQ
Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call
News Preview
NASDAQ | TSX: ACBEDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Tim...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
SLP
LISTED
NASDAQ
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its 2026 Virtual Investor Day, outlining how the Company is advancing an integrated, AI-enabled platform to support the evolving needs of the drug develop...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted an equity award on January 15, 2026 to Rita Thakkar, the company’s new Chief Accounting...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SN
LISTED
LSE
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder repair business with the most comprehensive suite of technologies available for rotator cuff repair (RCR)....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
News Preview
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.01.2026
PHARM
LISTED
EURONEXT
First Berlin Equity Research GmbH: Pharming Group NV | Rating: Buy
News Preview
Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
21.01.2026 / 16:13 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude ......
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
KDEV
LISTED
STO
Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin
News Preview
STOCKHOLM, SWEDEN – January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women’s Health company, for an exclusive semi-global license (excluding China and Japan) to its lead candidate drug tafoxiparin. Exeltis will fund pivotal...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
TEM
LISTED
NASDAQ
Tempus Announces the Launch of Paige Predict
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology applications that analyze hematoxylin and eosin (H&E) whole slide images to help inform testing decisions. The AI-powered solution is designed to pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
LEGN
LISTED
NASDAQ
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
News Preview
Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, reflecting a maturing and expanding body of evidence...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SKYE
LISTED
NASDAQ
Skye Bioscience to Present Poster at Keystone Obesity Conference
News Preview
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present a poster at Keystone’s conference, Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
GMAB
LISTED
CPH
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
SECT_B
LISTED
STO
TUM University Hospital adds pathology and ophthalmology to its Sectra enterprise imaging solution--boosts diagnostic efficiency for improved patient care
News Preview
LINKÖPING, Sweden, Jan. 21, 2026 /PRNewswire/ -- The university hospital TUM Klinikum Rechts der Isar (TUM Klinikum) in Germany expands its enterprise imaging solution from international medical imaging IT and cybersecurity company Sectra (STO: SECT B) by adding the modules for pathology and ophthalmology. This will provide their clinicians with t...
Themefolio
Profiler
Peergroup
© ActuNews
20.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma Announces its 2026 Financial Calendar
News Preview
Lyon, France – January 20, 2026, 18:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces its financial communication agenda for. Each publication will be released after Euronext market closing, unless otherwise specified . These dates are given as...
Themefolio
Profiler
Peergroup
© ActuNews
20.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma publie son agenda financier 2026
News Preview
THX Pharma publie son agenda financier 2026
Lyon, France – 20 janvier 2026, 18h CET – THX Pharma (Theranexus), société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui son agenda financier 2026. Les publications auront lieu après la clôture des march&eacut...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Bilan semestriel du contrat de liquidité avec Invest Securities...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
OSE
LISTED
EURONEXT
Half-Year Report on Liquidity Contract with Invest Securities
News Preview
Half-Year Report on Liquidity Contract with Invest Securities...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
LIVN
LISTED
NASDAQ
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2025 results on Wed., Feb. 25, 2026, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its fourth-quarter and full-year 2025 results prior to the call.
The audiocast will b...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
ACB
LISTED
NASDAQ
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
News Preview
NASDAQ | TSX: ACBEuropean grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis companyEDMONTON, AB, Jan. 20, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted co...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
ACB
LISTED
NASDAQ
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
News Preview
NASDAQ | TSX: ACBEuropean grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis companyEDMONTON, AB, Jan. 20, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted community...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
DFTX
LISTED
NASDAQ
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
News Preview
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the launch of Rerouting Minds, an educational campaign aimed at opening perspectives by inc...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CELC
LISTED
NASDAQ
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
News Preview
MINNEAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for filing its New Drug Application (“NDA”) for gedatolisib in hormone receptor positive (“HR+”...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
BAYN
LISTED
XETR
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
News Preview
Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innovative therapies from target identification through Investigational New Drug (IND) application. The agreement spans across all indications currently pursued by Bayer, initially focusing on cardio...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS20 January 2026 at 08.30 EET ...
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
News Preview
Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1].
Leuven, BELGIUM – 19 januari 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on...
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
News Preview
Atlas Special Opportunities, LLC heeft 2 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 50.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1.
Leuven, BELGIUM– 19 januari 2026 – 18u00 CET – Overeenkomstig artikel 15 van de W...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.01.2026
ILM1
LISTED
XETR
Medios AG enters market for medicinal cannabis
News Preview
Press release
Medios AG enters market for medicinal cannabis
Expansion of product portfolio with medicinal cannabis
Medios obtains exclusive distribution rights for Bedrocan® products in agreed European markets
Entry into an attractive growth market and strengthening expertise in existing indication areas
Berlin, January 19, 2026 – The Medios G......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.01.2026
ILM1
LISTED
XETR
Medios AG steigt in den Markt für Medizinalcannabis ein
News Preview
Pressemitteilung
Medios AG steigt in den Markt für Medizinalcannabis ein
Erweiterung des Produktportfolios mit Medizinalcannabis
Medios erhält Exklusivvertriebsrechte für die Bedrocan®-Produkte in vereinbarten europäischen Märkten
Eintritt in attraktiven Wachstumsmarkt und Stärkung der Kompetenz in bestehenden Indikationsgebieten
Berlin, 19. Ja......
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
Oxurion kondigt de tijdelijke opschorting aan van het financieringsprogramma bestemd voor investeringen in digitale activa en crypto-activa
News Preview
Leuven, BELGIË – 19 januari 2026 – 8u00 CET Oxurion NV (Euronext Brussel: OXUR), een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, heeft het investeringsproject in digitale activa en crypto-activa, zoals op 1 december 2025 aan de markt werd meegedeeld, herbekeken. Dit project had tot doel een alternatieve activakl...
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets
News Preview
Leuven, BELGIUM – January 19, 2026 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has reviewed the investment project in digital assets and crypto-assets, as communicated to the market on 1 December 2025. The objective of this project was to consider an alternative asset clas...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
